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Abstract
Osteoporosis is noted as one of the foremost causes of disability and morbidity worldwide (Rapp
et al., 2016). An osteoporotic fracture can result in significant debility, resulting in significant
financial burdens. Screening guidelines for osteoporosis are in place, but confounding variables
often lead to missed screening and treatment opportunities. Xu, Lombardi, Jiao, and Banfi
(2016) state that bone health is essential for maintaining quality of life and overall health and that
one out of two Caucasian women will suffer an osteoporotic-related fracture in her lifetime.
Current research supports identifying those at risk, screening, and potentially implementing
pharmacological treatment regimens to increase bone density once osteoporosis is diagnosed.
Numerous screening instruments are available to identify those at risk, but many women are
under-screened for this potentially debilitating disease. The purpose of this Doctor of Nursing
Practice (DNP) translational project is to determine if the implementation of an osteoporotic
fracture prevention workshop for Advanced Practice Registered Nurses (APRNs) impacts
screening practice patterns for perimenopausal female patients.
Keywords: Osteoporosis, osteoporosis screenings, fragility fracture, bone density
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Implementation of an Osteoporosis Workshop for APRN’s to Identify Female Patients at Risk
for Low Bone Mass
Osteoporosis is a bone disease characterized by low bone mass and deterioration of
skeletal bone tissue which often results in increased bone fragility and fracture (Black, Reid, &
Sandison, 2009). It is a common skeletal condition that is prevalent amongst postmenopausal
females when estrogen storage and production drops significantly. It is often referred to as the
silent disease and not detected until an osteoporotic fracture occurs, often preceded by a fall.
These fragility fractures are one of the leading causes of disability for the older population (Rapp
et al., 2016). A fragility fracture increases the risk of a subsequent fracture by 50% (Mendis,
Ganda, & Seibel, 2017). Age related bodily changes often affect numerous bodily systems which
includes decrease in sensory perception, decreased body mass, changes in visual acuity, and
neuro related conditions causing imbalance. Low bone mass (osteopenia or osteoporosis),
decreased vision acuity, and falls can perpetrate fractures that increase morbidity and mortality.
The impact of osteoporosis affects 200 million women worldwide with over nine million
fractures per year in the United States (Keshishian et al., 2017). The impact of direct medical
costs following a fragility fracture is estimated at $17 billion in Canada (Weng, Hess, Lynn, &
Litner, 2015) and $20 billion in the United States (U.S.) per year (Shuler, Scott, Wilson-Byrne,
Morgan, & Olajide, 2016). Xu et al. (2016) state the likelihood of a woman experiencing an
osteoporotic-related fracture in her lifetime is one out of two women. It is estimated that 10%20% of hip fracture patients die within the first year after the related fall/injury and risk of
premature death is elevated for at least 10 years (Gillespie & Morin, 2016). The impact, burden,
rehabilitation, and costs associated with these fractures are significant and often result in
permanent residence in an assisted living or skilled care living institution. The prevalence of
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osteoporosis is expected to climb as our population increases and ages. Evidence-based
guidelines for low bone mass screening and treatment are readily available, however research
reveals that osteoporosis remains under-diagnosed, under-screened, and under-treated, especially
in the non-Caucasian population (Golob & Laya, 2015).
Evidence-based screening tools are noted to be one of the most beneficial and reliable
ways to diagnose those at risk not only for osteoporosis but for current low bone mass and
density. However, it is estimated that millions of women are under screened for this serious
disease and providers lack consistency with their screening protocols. This translational project
seeks to explore if the implementation of an osteoporotic fracture prevention workshop will
impact and/or change pre-screening patterns by APRN’s for their female patients ages 45-64.
Background
Bone balance is determined by the activity of osteoclasts (break down bone tissue) and
osteoblasts (build new bone tissue). Well known major risk factors for the development of
osteoporosis include: female gender, advancing age, and estrogen deficiency. There are many
other risks that increase one’s risk for bone loss. Behavioral risks include: excess alcohol intake,
inadequate calcium and Vitamin D intake, tobacco abuse, lack of exercise, and diet (Golob &
Laya, 2015). Other risks include demographic factors such as race, height and body habitus, and
medical conditions such as rheumatoid arthritis, hypogonadal disorders, and
hyperparathyroidism. Medications, such as glucocorticoids, are attributed with significant risk
for bone loss especially during the first few months of use (Golob & Laya, 2015).
Prevention is a vital component in identifying those at risk or deemed a future risk for an
osteoporotic fracture. Recent studies identified by Xu et al. (2016) have shown that screening
rates for Medicare age women are as low as 30-48% over a seven-year time frame. The United
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States Preventive Services Task Force (USPSTF) has recommended universal osteoporosis
screening for women 65 years and older (at 2-year intervals), and targeted screenings for
younger women with identified risk factors (United States Preventive Services Task Force, 2018)
with a dual energy x-ray absorptiometry scan (DXA). Other reputable guidelines exist for the
U.S. and include those of the National Osteoporosis Foundation (NOF) (Siris et al., 2014) and
World Health Organization (WHO) (World Health Organization-4bonehealth, n.d.). In 2008
newer WHO screening guidelines were established based on fracture risk and served as a model
for lowering the risk with use of osteoporosis medicines. The new guidelines for treatment are
for postmenopausal women, any ethnicity or race, and for men age 50 and over (World Health
Organization-4bonehealth, n.d.). Three categories were specified as high risk groups and met the
Food and Drug Administration (FDA) criteria for FDA approved drug implementation. The three
groups include those with (1) a history of fracture of the hip or spine (2) those with a bone
mineral density (BMD) in the osteoporosis range (T-score of -2.5 or lower), and (3) those with a
BMD in the low bone mass or osteopenia range with a higher risk of fracture defined by the
fracture risk assessment tool (FRAX) score for a major osteoporotic fracture 10-year probability
of 20% or higher or a hip fracture 10-year probability 3% or higher.
APRNs play a vital role in the prevention and screening aspect of healthcare. Patients
often choose to see an APRN to provide comprehensive primary care which includes
preventative counseling and recommended screenings. Once osteoporosis is diagnosed by a
provider, bone mass loss can often be reversed by diet, exercise, vitamin supplementation, and
pharmacologic therapy. However, studies indicate low screening rates for women ages 50 and
greater in the U.S. from 2008-2014 (Gillespie & Morin, 2016) with screening among women
ages 50-64 years dropping steadily. Gillespie and Morin (2016) state that recent studies indicate
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screening rates state that recent studies indicate screening rates were low with the average
screening rate for women ages 50-64 only 21.1% and 26.5% for ages 65-79.
Problem Statement
Prevention of osteoporosis should be of prudent concern for health care providers
because most women are not screened routinely. The goal of osteoporosis screening is to identify
those women at increased risk of low bone mass and possible future fracture who would benefit
from an intervention such as medication administration to decrease that risk (Jiang et al., 2016).
Numerous non-radiologic risk assessment tools exist for screenings such as the FRAX Tool
which uses multiple risk factors that can be used with or without a BMD to predict the 10-year
probability of a hip fracture or other major osteoporotic fractures (Chen et al., 2016). The Simple
Calculated Risk Estimation tool (SCORE) (Appendix A) is based on race, age, weight, previous
fracture, history of autoimmune disease and use of estrogen therapy (University of WashingtonOsteo ED, n.d.). This non-invasive and non-radiologic screening tool can play a key role in
identifying those younger individuals at risk for low bone mass. Recent data indicates that less
than one in four privately insured women (65+ years) are screened for primary prevention by
their healthcare provider (Gillespie & Morin, 2016) and younger women, less than 65 with
known risk factors, are not screened until well after a fracture occurs. Numerous FDA approved
osteoporotic drugs are available and have been shown to reduce the risk of fractures by 20-50%
(Elders et al., 2017). Inconsistent screenings can lead to potentially disabling fractures, undue
pain, rehabilitation, significant medical bills, relocation to assisted living or skilled living
facilities, increased mortality, and possible mortality (Black, Reid, & Sandison, 2009).
Coordination of care and screenings are often managed between numerous providers and
specialists which unintentionally creates a gap that assumes screenings are being managed by
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others. There are numerous barriers that exist in implementing these guidelines which include
knowledge, time, insurance challenges, and financial barriers. A recent interview with Debby
Godwin, a nurse practitioner (NP) in a family practice setting, illustrated her confusion with
osteoporosis screenings (D. Godwin, personal communication, October 12, 2018). She reflected
she should be utilizing the screening tools more efficiently but time restraints in a busy setting
often negate the tool being used. Debbie also stated that denials for DXA scans were a great
concern for females under age 65 and are often not covered by the insurance companies-so
females often lack screenings.
Needs Assessment
Gillespie and Moran (2017) state that screening rates for osteoporosis in women between
the ages of 55 and 64 decreased by 44% and non-Hispanic women were least likely to be
screened. This study concluded only 21% of women (age 55-64) were screened for osteoporosis
and screening rates were low for women >65 years of age. The USPSTF has specific guidelines
in place stating osteoporosis screening should begin at age 65 or for those with identifiable risk
factors. Mortality rates post hip fracture are 20-25% (Rapp et al., 2016) within the first year with
50-60% having some permanent disability. However, numerous gaps have been identified in
guideline screenings and current practice patterns. Jiang et al. (2015) state that there is no
consensus as to which menopausal or early menopausal women should have screening done via
DXA. Often the provider is unaware as to who will manage osteoporosis screenings if a patient
sees multiple providers or specialists. Other barriers to screening include lack of screening tools
available, insurance, time constraints with patients, and limited availability of resources for those
without funds. Rural health clinics face other barriers including lack of access to DXA imaging
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and bone density testing. Consistent and preventative screenings are a must to catch those at risk
now or deemed a future risk of fragility fracture.
A pre-project needs assessment was explored targeting advanced practice nurse
practitioners of the Cobb/Cherokee United Advanced Registered Nurse (UAPRN) chapter. The
needs assessment was created and delivered by the PI in a survey format. It asked specific
questions regarding (1) awareness of current USPSTF guidelines regarding osteoporotic
screenings and (2) the need for an osteoporosis risk assessment workshop. Results from the
survey indicated 33.33% of the total participants (n = 24) were not aware of current screening
guidelines and 83.33% indicated a need for an osteoporosis risk assessment workshop.
This paper will describe the components of a comprehensive needs assessment that was
completed as well as the underlying rationale for choosing the topic for this scholarly research
project. Prevention is a key component in identifying those at risk or deemed a future risk for an
osteoporotic fracture. The needs assessment focused on osteoporosis fracture prevention as a
phenomenon of interest. Practicing APRNs were identified due to their authorized ability to
perform screenings and order additional imaging if warranted. The specific areas of interest
included knowledge of current osteoporosis screening guidelines, utilization of additional
screening tools, and practice patterns for those at risk for osteoporosis related fractures.
Objectives and Aims
The purpose of this DNP translational project was to determine if the implementation
of an osteoporotic workshop impacts the screening patterns of APRNs. Knowing in advance that
screening rates are low for all women, the aim of the project was to empower these providers
with tools that will identify those at risk or a future risk of either osteoporosis or a fragility
fracture. The prevention program included an educational workshop, introduction of
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supplemental screening tools per the World Health Organization (WHO), National Institute of
Health (NIH), and the United States Preventive Services Task Force (/USPSTF) guidelines and
recommendations, interpretation of BMD imaging, and advanced alternative to radiologic
imaging devices such as ultrasound scanning.
Rural health clinics face other barriers including lack of access to DXA imaging and bone
density testing. The implementation of fall prevention programs is standard in assisted living
facilities, skilled nursing homes, and community centers but rare is a program that combines a
fall and osteoporosis prevention program (Mendis et al., 2017). The utilization of non-radiologic
imaging tools could be a vital key in identifying those at high-risk for problems. Although
screening recommendations exist, application and use are a valid problem. The clinical practice
questions this project aims to answer are:
1.

Will APRN’s who attend an osteoporosis risk assessment program implement the
SCORE tool into practice?

2.

Will the EBPQ tool identify APRN’s who will implement change into practice?

3.

What work/environmental factors are associated with the implementation of the
SCORE tool into practice?

4.

What are the perceived barriers that prevent implementation of the SCORE tool
into practice?
Review of Literature

Osteoporosis is a major health problem and concern that affects people not only
nationally but globally as well. As the U.S. population ages, so does the prediction in the
increase of osteoporosis. Although evidenced based guidelines are in place to help with
screening and treatment, osteoporosis remains underdiagnosed, undertreated, and under screened
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(Golob & Laya, 2015). Literature is consistent that osteoporosis remains one of the most
debilitating and chronic diseases amongst postmenopausal females with increasing risk of
fractures after age 50 (Kling, Clarks, & Sandhu, 2014). The USPSTS warrants there is
resounding evidence that bone mineral and measurement tests are accurate in diagnosis and
predicting low bone mass and osteoporosis (USPSTF, 2018).
The literature is consistent that osteoporotic fractures are associated with increased
morbidity and mortality for numerous years after a fracture (Gillespie & Morin, 2016). There is
also decreased quality of life, substantial medical costs, and a leading cause for disability (Rapp
et al., 2016). Mendis et al. (2017) concluded that as many as 70%-80% of patients with an
osteoporotic fracture are not being adequately screened, diagnosed, or treated. Patients with low
bone mass are at high risk for current and potential future fragility fractures that will only be
diagnosed after a fracture occurs (Keshishian et al., 2017). It is estimated that total costs related
to osteoporosis in the US are more than $19 billion dollars and the costs are expected to rise by
almost 50% by 2025 (Shuler et al, 2006). Health education and health promoting lifestyle
behaviors can impact bone health. Exercise, adequate calcium intake, healthy diet, and vitamin D
supplementation are all strategic influences that can positively impact bone mass. Genetics and a
family history of osteoporosis can also impact bone mass in a negative way. Research promotes
prompt evaluation, screening, and treatment of osteoporosis and is indicated to prevent further
fracture-related conditions as well as morbidity and mortality.
The extent to which providers follow the USPSTF guidelines in screening, specifically
Medicare age females, is unclear but studies conclude screening rates between 30-48%
(Amarnath, Franks, Robbins, Xing, & Fenton, 2015). Rural areas face other challenges and DXA
imaging is negatively impacted with a 20% drop in osteoporosis screening rates when a DXA is
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located greater than 5 miles from the patient (Shuler et al., 2016). There is inconsistent universal
consensus as to when to begin screenings as stated by Golob and Laya (2015). The FRAX tool is
one of the most popular yet underused tools in identifying those at risk. Conflicting decisions
occur when providers suspect a patient could be at risk yet hesitant to screen due to unnecessary
costs and imaging.
Numerous non-imaging tools have been used by clinicians for decades with accurate
specificity in results as compared to BMD imaging. The results of a phone survey on rural West
Virginia females, 65years and greater, confirmed that the FRAX phone survey is as reliable as
DXA in detecting osteoporosis or osteopenia but fails to identify women younger than 65 at risk
(Shuler et al., 2016). Despite available current guidelines, research states less than 25% of
women 65 years and older underwent bone mass screening from 2008 to 2014 (Gillespie &
Morin, 2016). Findings are reliable that there are inconsistencies related to when to screen for
osteoporosis in females, often leading to missed opportunities for treatment to prevent further
bone loss.
Risk Factors
Bone mineral density is associated with several factors such as age, menopause status,
weight, body mass index (BMI), and socio-economic class (Haryono & Prastowo, 2017).
Postmenopausal females are much higher risk than their male age equivalent counterparts. Kling
et al. (2014) notes that the lifetime risk of any osteoporotic fracture is 40%-50% for women and
13%-22% for men which is considerably higher than other major diseases. Risk factors include
family history of osteoporosis, advancing age, female gender, smoking, excessive alcohol use,
lack of exercise, a diet low in calcium and vitamin D, thin frame or below normal body mass
index, hyperthyroidism and hyperparathyroidism, glucocorticoid use, premature menopause,
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post-menopausal state (estrogen deficiency), excessive dieting or eating disorders, and being of
European or Asian descent. The use of daily dose glucocorticoids as low as 2.5mg to 7.5mg can
significantly decrease bone density and most noted in the first few months of use (Golob & Laya,
2015). They also note that most osteoporotic hip fractures occur due to falls and it is imperative
to assess environmental factors that may contribute to falls such as hazards in the home, impaired
balance and decreased proprioception, and medical conditions such as hypotension which can
cause significant dizziness and balance issues.
Mortality
Currently, there are over two million osteoporotic related fractures in the United States
annually with rates expected to increase to three million by 2025 (Gold et al, 2019). Fifty percent
of U.S. women will experience an osteoporosis-related fracture in her lifetime with hip fractures
being the leading cause of long-term nursing home care (Kling et al., 2014). In the Swedish
SENIORLAB study, osteoporosis was found to be the most important risk factor for all causes
of mortality in a relatively healthy population of persons ages 60-99 (Gutzweller, 2018).
Findings of this study state that a clinical diagnosis of osteoporosis had a higher relative risk for
mortality than diabetes type 2 and hypertension.
Literature is consistent that there is worldwide under-screening and under-treatment for
osteoporosis. Low bone mass, left undetected, can lead to burdensome fractures and decreased
quality of life. Mortality rates for hip fractures can be as high as 45% one-year post fracture. The
USPSTF estimates that by the year 2020, 12.3 million individuals in the U.S are expected to
have osteoporosis (USPSTF, 2018). The overall impact related to these fractures is often difficult
for a person or family to manage.
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Costs
The burdens and costs related to osteoporosis are seen globally. It has become a major
U.S. health problem affecting millions of adults >50. Falls, fractures, increased morbidity and
mortality, hospitalizations, lost days of productivity, depression, and decreased quality of life are
some of the most impactful consequences related to osteoporosis. It is often called the silent
disease until a fracture occurs and thus causing significant impact on the quality of daily living
and life. The yearly cost of osteoporotic fractures is approximately $2 billion and expected to
increase with our aging population (Daroszewska, 2015). The majority of these costs are related
to hip fractures and their high mortality and morbidity rates. The costs and annual fracture rates
associated with osteoporosis are estimated to rise by 50% by the year 2025 (Kling et al., 2014).
Osteoporosis is one of the foremost causes of disability and morbidity worldwide in older
adults (Rapp et at., 2016). Individuals are often left with chronic pain and disability due to these
fragility fractures. The loss of independence associated with fractures often leads to depression,
isolation, altered daily engagement activities, and social withdrawal. Only 50% of hip fracture
patients regain their functional status after the fracture (Tsai, 2019).
There are often socioeconomic factors related to the prevalence of osteoporosis as seen in
non-citizens of the U.S. and the less educated. Osteoporosis is also more prevalent in those who
are unemployed and with lower incomes. Individuals who rely on social security as their primary
source of income often become food insecure and make poor food choices due to lack of income
(Black et al., 2009). The soaring medical costs related to fracture care can leave an individual
without adequate resources for a healthy diet and lifestyle. Post fracture care can leave an
individual with little financial resources to live on. Difficult choices often must be made for
long-term care or assisted living arrangements.
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Tools
The goal of osteoporosis screening is to identify individuals who are at increased risk for
low bone mass and would benefit from an intervention to decrease the risk. For the purpose of
this project “tools” will include the non-radiologic risk assessment tools/instruments that can be
done by either the provider or the patient. Primary osteoporosis (without underlying disease)
increases with age and impacts different races/ethnicities differently. The USPSTF found there is
adequate evidence that risk assessment tools are moderately accurate in identifying a person’s
risk of osteoporosis (USPSTF, 2018).
Numerous risk assessment tools have been validated and proven effective in identifying
younger women who are at risk for low bone mass and at risk for the development of
osteoporosis (Golob & Laya, 2015). During the last several decades newer screening tools have
been acknowledged and currently replace the DXA as a first step screening process in the
younger population to reduce unnecessary radiation exposure and the burdensome costs
associated with DXA. Three of the most validated screening tools include SCORE, OST
(osteoporosis self-assessment tool), and ORAI (osteoporosis risk assessment instrument). These
tools aim at identifying persons with low bone mass who should be further sent for diagnostic
imaging. BenSedrine et al. (2000) state that screening whole populations is unreasonable and not
necessary. The study by BenSedrine et al. (2000) on women 45 years and older (n = 4,035)
concluded that the SCORE tool could be used with qualified confidence to exclude patients who
should not be imaged for low bone mass. Jiang et al. (2016) explain that early DXA screening
and when to initiate is confusing for providers and evidence is lacking. In his study the SCORE
tool had the highest sensitivity (92%) in predicting women who were diagnosed with
osteoporosis with DXA. In another study of 211 female patients ages 45-88 years (average age
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57), the SCORE tool had the highest sensitivity (95.2%) in identifying women with low bone
mass after sent for imaging (Ahmadzadeh, Emam, Rajael, Moslemizadeh, & Jalessi, 2013). Data
from 1,279 postmenopausal women were analyzed in a study by Lydick et al. (1998) and
indicated the SCORE prescreening tool could decrease radiologic DXA imaging by 30%. The
newest recommendation is to prescreen women younger than age 65 by using one of clinical risk
assessment tools such as FRAX, OST, and SCORE (Cauley, 2018).
One of the most widely used tools is the FRAX tool-which estimates a 10-year
probability of either a hip fracture or other major osteoporotic fracture with or without a BMD
score. There are more than 30 different risk factors listed on various screening guidelines. A
FRAX score of 20% or higher for a major osteoporotic fracture or a 3% or greater score for a hip
fracture warrants screening with the DXA scan. Golob and Laya (2015) state that some authors
have found that there are other tools more sensitive than FRAX in identifying women with low
bone mass.
DXA scan
Dual-energy X-ray absorptiometry, DXA scan, is the noted gold standard and premium
method for identifying a patient with osteoporosis (Gillespie & Morin, 2016). It is the preferred
method in diagnosing osteoporosis and observing T- scores after the implementation of
osteoporosis medications. The current USPSTF guidelines recommend screening for
osteoporosis in women 65 years and older as well as women less than 65 years who are at
increased risk of osteoporosis as determined by some type of a clinical risk assessment tool
(USPSTF, 2018) when guidelines were updated at that time. However, there is no consensus on
when to initiate a DXA screening for early post-menopausal women less than 65 years of age.
Jiang (2016) stated in a recent major study comparing various risk assessment tools that in using
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the USPSTF guidelines only 24% of the women with osteoporosis would need a DXA compared
with 92% using the SCORE tool.
The Choosing Wisely Initiative is a campaign founded by the American Board of Internal
Medication (ABIM) which aims to decrease unnecessary tests, medical procedures and
treatments. (Amarnath, Franks, Robbins, Xing, & Fenton, 2015). It does support DXA imaging
in female patients younger than 65 with known, identifiable osteoporosis risk factors. In a survey
reported by (Amarnath et al., 2015), over 40% of women who were referred for a DXA did not
meet guidelines for imaging.
Education of Providers
It is imperative that healthcare providers are familiar with the USPSTF and other
healthcare screening guidelines. As newer evidence from data is analyzed, healthcare practice
changes must follow. Amrarnath et al. (2015) evaluated different screening rates amongst a
regional healthcare system and reported that their analysis revealed misuse and overuse of DXA
screening for women at low risk for osteoporosis. A significant barrier is that clinicians and
providers received little support from the electronic medical record (EMR) system with regards
to decision making on the optimal use/ordering of a DXA. Although many older patients are sent
reminder letters to alert them when a DXA screening is due, many providers lack the decisionmaking support when a younger female patient might need to be screened due to risk factors.
The two most primary mechanisms of fragility fractures are osteoporosis and falls (Rapp
et al., 2016). Many rural areas lack availability for fall prevention programs. Once osteoporosis
is detected, it is the responsibility of the healthcare team to explore optional methods to reduce
future fragility fracture risk. It requires the coordination of care between numerous team
members to offer a supportive approach and program plan. Exercise is one of the most effective
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fall prevention strategies and also improves balance, muscle mass and strength, as well as bone
strength, yet research shows that evidence is lacking on bone strength and aerobic exercise
programs (Yoo, Jun, & Hawkins, 2010).
Medication
The use of anti-osteoporosis (AOM) drugs have shown to maintain and even increase
bone density (Balaji, 2016). Several known classes of medications are currently used to treat or
prevent osteoporosis: bisphosphonates, monoclonal antibodies, hormone therapy, synthetic
parathyroid hormone, and Selective Estrogen Receptor Modulators (SERM). Bisphosphonates
and monoclonal antibody medication work by interfering with the breakdown of bone
composition by the osteoclasts. SERM’s and estrogen medication block osteoclast activity but to
a lesser degree. Synthetic parathyroid medications increase the production of osteoblasts-the
cells that actually build bone matrix.
Dr. David Slovik, an Endocrinologist at Harvard-affiliated Massachusetts General
Hospital, stated that the rates of hip fractures in the U.S. declined mainly in part to the use of
bisphosphonate medication and earlier screenings (Balaji, 2016). Yu et. al. (2019) examined the
mortality rates after anti-osteoporosis medication adherence in adults at year one, three, and five
post hip fracture. This was a population-based cohort study of over 5,000 participants in which
one half were treated with medications and the other group were not treated. Results from the
study concluded that survival rates were significantly higher in the “good adherence” group
when compared to those in the non-adherence group (p < 0.0001). The mortality rates at year
one, three and five were 8.6%, 23.7%, and 32.2% for the treated group as compared to 11.8%,
27.8%, and 39.0%. in the non-treated group (Xu, Lombardi, Jiao, & Banfi, 2016). The most
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frequently prescribed medications in this study was Alendronate (57.5%), Raloxifene (19.8%),
followed by Calcitonin (17.8%).
A first fragility fracture is a strong predictor of a post-secondary fracture (Gillespie &
Morin, 2016). Data collected in the FREEDOM trial showed treatment gaps in clinical practice
to prevent secondary fractures (Palacios et al., 2015). In this study, data from the U.S. showed
only 7-19% of patients were treated with an AOM after a first fragility fracture and similar
under-treatment globally. In the FREEDOM trial, patients given Denosumab (monoclonal
antibody medication) lowered the risk for secondary fragility fractures by 39% in all risk
subgroups independent of age. Several AOMs can be given to patients with low bone mass
(osteopenia) with repeat DXA in 2-5 years dependent upon risk factors.
Several studies indicate that even after osteoporosis is diagnosed, there is impediment to
treatment (Golob & Laya, 2016 and Mendis et al., 2017). In the Mendis et al. study (2017) 87
patients, ages 55 years and older, were followed up by their provider after a low trauma fracture.
Results from his observational retrospective study indicated 63% were not sent for bone density
testing, vitamin D levels were not checked in 41%, and no pharmacologic therapy started in over
63% of the patients. Barriers to treatment include lack of knowledge, lack of awareness (multiprovider), lack of owning the responsibility for treatment, cost of therapy/medication, low rates
of referral to specialists for osteoporosis management, and medical comorbidities.
The current recommended guidelines when using AOMs is to treat for five years
followed by full re-evaluation with a physical examination and repeat BMD (Golob & Laya,
2015). At that time, if no new high-risk factors have come into play, the patient can be monitored
closely. All patients are encouraged to get adequate sources of calcium as well as vitamin D in
their diet. The Institute of Medicine as well as the National Osteoporosis Foundation
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recommends 1,200mg of calcium daily for women 51 years and older and 700-1,000mg of
vitamin D daily dependent upon age. The National Osteoporosis Foundation recommends bone
density testing every 3-5 years after medication onset as well as possible bone turnover
biochemical markers (National Osteoporosis Foundation, n.d.).
Prevention
Literature is consistent that there is under screening for osteoporosis, lack of consistency
in screenings, and lack of treatment initiation. The primary goal is the prevention of osteoporotic
fractures throughout a lifetime with special attention to any female, regardless of age, who may
have risk factors that pose a threat to optimal bone health. Prevention includes risk assessment
screenings, bone density screenings, adequate exercise, a diet rich in calcium and vitamin D, as
well as lowering a modifiable risk that may impede strong bone matrix.
Prevention can begin as early as age 30 when bone density starts to decline slowly.
Daroszewska (2015) stated that a healthy lifestyle, daily physical activity, and a diet high in
soluble fiber increase intestinal absorption of calcium thereby increasing bone mineral density.
In a randomized clinical trial with over 3,000 healthy, ambulatory females, those who were given
a treatment of 800 international units (IU) of Vitamin D daily showed a 32% reduction in
overall fractures and a 43% decrease in hip fractures (Daroszewska, 2015). Tan, LaMontagne,
English, and Howard (2016) did a cluster-randomized trial which compared workplace groups
that were placed either in a control group or the intervention group. The intervention group
received three osteoporosis prevention workshops. Comparisons were made six months after the
intervention which showed the work-intervention group had improved calcium daily intake and
increased load/weight bearing physical activity (p < .0005) when compared to the control group.
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It is estimated that as much as 23% of osteoporosis is due to lack of physical activity (Tan et al.,
2016).
Theoretical Model
The model used for this project is the RE-AIM Framework developed by Russ Glasgow,
Shawn Boles, and Tom Vogt in 1999 (Gaglio, Shoup, & Glasgow, 2013). The Reach,
Effectiveness, Approach, Implementation, and Maintenance model grew from the need to
establish validity of the implementation of healthcare promotion and the need to report key
findings. It was originally created to assess the dissemination of clinical healthcare practice
changes and widely used today by many key stakeholders and organizations. RE-AIM (Figure 1)
follows a logical sequence from thought to adaptation and implantation of research to allow for
more effective evaluation and reporting of initiatives.
The Reach in RE-AIM is the targeted audience and represented those individuals who
would like to participate in a new initiative. The APRNs in this project were the population that
had been chosen as they expressed interest and need to learn about osteoporosis screening. The
project plans to reach the members of the Cobb/Cherokee APRNs who were actively seeing
female patients, who ranged at least from 45-64 years of age, in their practice setting. The
Effectiveness in RE-AIM is the impact that an intervention or initiative had on an outcomepositive or negative. The intention for this project was the APRN’s would embrace an evidencebased and validated tool to screen for low bone mass after presentation by the PI. The
implementation of the SCORE tool into APRN practice was measured post project. The
Adoption section of RE-AIM focused on the representativeness of a group or setting who were
willing to initiate a program. The APRNs who screened using the SCORE tool were encouraged
to adopt the tool into practice. The Implementation of RE-AIM referred to the target groups
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faithfulness to all elements of an initiative or intervention protocol. The APRNs were asked to
use the SCORE screening tool for a total of four weeks. The Maintenance portion of RE-AIM
was the extent to which an organization validated and institutionalized the said intervention or
imitative as part of practice. The goal of the project was to arm APRNs with additional tools to
prescreen females for low bone mass and capture those at risk by implementing the SCORE tool
into everyday practice.
Figure 1
REAIM Framework

Note. This figure demonstrates the REAIM Framework. Reach your intended target populationEfficacy or effectiveness- Adoption by target staff, settings, or institutions-Implementation
consistency, costs and adaptations made during delivery-Maintenance of intervention effects in
individuals and settings over time (Gaglio et al., 2013).
Methodology
The project used an evidence-based study design to incorporate clinical expertise and the
best scientific evidence to impact osteoporosis screening patterns in APRNs to identify women at
risk for low bone mass. The overall purpose of this project was to increase knowledge of APRNs
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that low bone mass and osteoporosis can be suspected at ages less than 65 using the SCORE tool.
A comprehensive educational osteoporosis workshop was given to interested APRNs bringing
awareness of the need to screen females ages 45-64. The project consisted of a planning phase,
project implementation phase, and post workshop analysis phase. After post implementation of
the project, a descriptive analysis was completed to identify if APRNs were able to implement
the SCORE tool into practice and identify any barriers that prevented them from doing so.
Setting
The project took place at the healthcare setting where the APRN participants were
employed. These areas included APRNs working in Primary Care/Internal Medicine, Women’s
Health, Rural Health, or Health department. If the participant was not employed in one of these
places, they could be employed in a different area so long as they fulfilled the requirement of
seeing female patients 45-64 years of age. The participants could be part time, full time, or per
diem and used the screening tool SCORE on female patients ages 45-64. The educational
workshop was held at a local senior assisted living center for the Cobb/Cherokee UAPRN
chapter members that expressed interest in attending. The setting included seating, an audiovisual media center, and access to break rooms.
Study Population
The study participants consisted of APRNs (Cobb/Cherokee chapter) of the nursing
organization United Advanced Practice Registered Nurses of Georgia. Participants who attended
the workshop were asked to volunteer for this project if they met the inclusion criteria. All
consent forms and instructions for the participants were given at the workshop. The attendees at
the workshop were encouraged to complete the workshop even if they had no plans to participate
in the project. Inclusion criteria included being a member of UAPRN, holding an active APRN
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license without restriction in the state of Georgia, and current employment in Primary Care,
Internal Medicine, Women’s Health, or Rural/County Health. The exclusion criteria included
APRNSs who did not meet the previous stated criteria or presently using the SCORE tool in
practice regularly.
Project Interventions
The planning phase of this project included an educational osteoporosis workshop that
preceded the start of the project phase. Upon arrival, participants checked in at the registration
table, signed a consent form after explanation of the project by the PI (Appendix B), confirmed a
current email address and created a personal identifier number (ID) (the first letter of their first,
middle, and last name, and the year of birth). After participants checked in and were seated, the
PI handed out and explained the Practice Demographic Characteristic Survey (Appendix C) and
Evidence Based Practice Questionnaire (EBPQ) (Appendix D). Each participant was given
instructions to place their created ID number on the top of the forms. The PI collected all forms
and placed them in a sealed envelope along with the master list of the ID numbers and email
addresses. Those participants who chose not to participate in the project were allowed to attend
the osteoporosis workshop. A one-hour osteoporosis presentation was given by the PI covering
osteoporosis, bone formation and resorption, risk factors, screenings, current guideline
recommendations, and impact on healthcare. During the osteoporosis workshop, the PI
introduced the risk assessment tool called the Simple Calculated Osteoporosis Risk Estimator
(SCORE) to be used during this project. Instructions on the use of the SCORE tool were given
during the presentation. After completion of the workshop all attendees were asked to complete
an evaluation of the workshop (Appendix E). The workshop evaluation summary was formatted
using a Likert scale. It was created by the PI to determine the impact of the workshop on
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attendees (even if they did not volunteer for the project) in the ability to comprehend the impact
of osteoporosis on females, the need for screening, and ability to use the SCORE tool.
Interested APRNs who expressed desire to participate in the project were encouraged to
implement the use of the SCORE tool into their practice for the next four weeks to their female
patients between the ages of 45-64. The PI sent a weekly email reminding the participants to use
the SCORE tool in practice for the next four weeks. After completion of the four-week
timeframe for implementing the SCORE instrument, the participants were sent a link to complete
a Post Project Implementation survey (PPIS) via Qualtrics (Appendix F). The participants were
asked to enter their ID number that was chosen at the start of the project and include it on the
survey. The PPIS identified whether the APRN was able to implement the SCORE tool into
practice. If the participant was unable to implement the tool into practice they were given a
checklist to identify barriers to implementation of the SCORE tool.
Outcome Measures
Several validated tools were used for this project after a complete and comprehensive
review. At the workshop, each subject was given the Evidence Based Practice Questionnaire
(EBPQ) to determine their current practice patterns regarding knowledge, attitudes, and use of
evidence-based practice in their current healthcare setting. The EBPQ was developed by
Professor Dominic and Dr. Penney Upton (Upton & Upton, 2006) with the sole purpose to gather
information from healthcare professionals on their attitudes and knowledge regarding evidencebased practice. The instrument focused on three main areas: attitudes, knowledge, and use of
evidenced based practice. It was a 24-item questionnaire with a seven-point (1 = never and 7 =
frequently) Likert rating scale. It’s ease of use and straight forwardness made it a desirable
instrument to use across the various educational levels of those taking the tool. The Cronbach’s
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alpha scores ranged from 0.70 to 0.93 (a > 0.7 to 0.93). The Practice Demographic
Characteristics survey was an instrument created by the PI and was used to assess demographic
and practice setting specifics of each participant. All participants who attended the workshop
were asked to complete the survey. It consisted of eight questions with multiple choice answers.
The Simple Calculated Risk Estimation score instrument (SCORE) (University of WashingtonOsteo ED, n.d.), is a non-invasive and non-radiologic risk assessment tool that can play a key
role in identifying women less than 65 years of age at risk for osteoporosis and potential future
fractures (Pecina, Romanovsky, Merry, Kennel, & Thacher, 2016). The participants were asked
to implement the SCORE tool into practice for four weeks. The participating APRNs were then
emailed the Post Project Implementation Survey (PPIS) after completion of the four-week
SCORE tool use which will specifically measure any work/environmental factors associated with
the implementation of the SCORE tool into practice as well as any perceived barriers that
prevents implementation of the SCORE tool into practice. The survey was created by the PI and
consisted of two questions to be answered by the participants one week after completion of the
project.
Benefits/Risks
The goal of this project was to increase screening patterns of the APRNs. There was
negligible physical harm in attending a workshop and implementing evidence-based practice.
The risk for the APRN was not identifying those women at risk. As with any radiologic x-ray,-a
participant could be exposed to a small amount of radiation if the provider deemed they need to
have a DXA scan due to their SCORE evaluation. The decision to have the DXA scan done was
solely the decision of each patient. There could be slight stress or psychological harm should a
patient score as high-risk and the DXA scan order be placed or discussed with the patient. There
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was minimal risk for any undue physical or psychological harm, stress, or legal complications for
the APRN’s participating in the project. Use of the SCORE tool could extend the patient visit by
an additional 5-7 minutes. The participant may elect to opt out of the project at any time without
any questions or explanations asking about their decision.
Subject Recruitment
Recruitment for this project used the convenience sampling method of the
Cobb/Cherokee UAPRN chapter members of United Advanced Practice Registered Nurses
(UAPRN). The PI sent an email to the county chapter members inviting them to an osteoporosis
workshop and recruited members to participate in the DNP project at the conclusion of the
workshop. The email was sent four weeks before the workshop start date. Interested APRNs
were able to click on the link in the email and confirm their plans to attend. A confirmation email
was then sent to those APRNs who wished to attend the workshop given by the PI with a
reminder email one week prior to the workshop. The acceptance to participate in this project was
voluntary and subjects could opt out or discontinue participation at any time. APRNs could still
attend the workshop should they choose not to participate in the project.
Consent Procedures
After completion of the osteoporosis workshop, the PI asked for volunteers to participate
in the project. The APRNs who expressed a desire to participate were given an informed consent.
They were asked to fully complete it after careful review. Any questions the participants had
were answered by the PI. The consent form addressed each area of the project. The PI provided
and collected the signed consent forms at the workshop and placed them in a sealed, private
envelope for safety and security measures. The PI explained to all APRNs participating that no
coercion or undue influence would be used during this project and that they may opt out of the
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project with no penalty. Minors were not involved in this project as the participants were 21
years of age or older. IRB approval was received by the respective entities prior to the start of
the project (IRB Approval).
Subject Costs and Compensation
The study participants were not expected to incur any out of pocket financial costs other
than local travel mileage to the workshop. The educational workshop for the Cobb/Cherokee
chapter members was promoted to all active chapter members and participation in the project
was not a requirement to attend. All workshop attendees were provided a complimentary meal by
the PI at no additional charge. There was no other project compensation awarded to the study
participants. The dinner workshop presentation lasted approximately 1.5 hours and the attendees
were invited to stay an additional 15 minutes if they chose to be included in the project. The
incentive for participation in the project was the valuable education the APRNs received in
attending a free educational workshop on osteoporosis and its detection, as well as implementing
evidence-based practice into their workplace. APRNs who attended the workshop each received
a one hour continuing education unit approved by the American Academy of Nurse Practitioners
(Appendix G) after completion of a post-workshop survey created by the PI (Appendix E).
A weekly project reminder email and one post project survey was sent to each participant
using their home email. The use of personal emails was used to avoid employee restrictions of
personal email use while at work. Time commitment by the subject participants was minimal by
only reading a short weekly email and answering several questions on the post project survey.
Project Timeline
A detailed timeline for the project can be found in Appendix G. The implementation of
the project started with the educational workshop in September 2019. Participants in the project
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were asked to use the SCORE tool for a total of four weeks on a regular basis. One week after
completion of the four-week SCORE tool use, the PPIS was sent to each participant to complete.
The project’s completion date, to include all analysis and interpretation, was completed in
January 2020.
Resources Needed/Economic Considerations
There were minimal financial costs encumbered by the PI associated with the planning
and implementation of this project. A local West Cobb-Marietta, GA senior living center offered
the use of their facility to host the osteoporosis workshop free of charge. The venue had ample
parking and no financial obligations for use was noted. No other charges were associated with its
use for the project. The center provided a large room to seat all workshop attendees, a kitchen for
meal service, restrooms, and necessary media equipment for the workshop presentation. Other
major resources included administrative items such as meals costs of the attendees, paper,
printed workshop handouts, and mileage associated with travel to and from the workshop. The so
noted financial costs were paid by the PI. The UAPRN Cobb-Cherokee chapter allowed free
web/email use of its site to deliver the invite to paid members for the project. Members of the
Cobb/Cherokee members pay a yearly membership fee of $100 to stay active within the chapter
to receive emails and invites to workshops and dinner programs. The post project
implementation survey was delivered through the online Qualtrics website at no charge to the PI.
The creation of the CE unit by the PI followed all AANP guidelines and there was an
additional cost by the PI to meet these guidelines and the use of the AANP logo on the CE. All
expenses incurred were paid by the PI.
The results of the project were formulated into a poster which was created by the PI and
presented at the Atlanta Unity Conference in October 2019. Costs associated with the poster
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presentation included printing of poster, conference fees, travel to and from the conference,
hotels fees and charges, and meals. All costs were the sole responsibility of the PI.
Evaluation Plan
Data Maintenance/Security
All participants’ privacy was maintained throughout the project. Each NP created an
identifier number to use when reporting their results and no names or other identifying
information was released to the PI during this project. All forms were collected at the workshop
and stored by the PI in the PI’s locked desk in a locked personal office. The surveys completed
via Qualtrics were stored on the PI’s computer for this project and was password specific and
locked. No audio or video recordings were used. Data was entered weekly into the PI personal
computer using IBM Statistics 25 SPSS and stored securely. All records, data, and identifiers
will be stored for three years per GCSU policy and then destroyed. No future risk of harm to
participants is foreseen.
Data Collection
There were four tools that the PI collected and interpreted for data analysis. The tools
were completed by participants who attended the workshop and those who proceeded in the
project. The first tool to be completed was the Practice Demographic Characteristic Survey
(Appendix C). The demographics survey was created by the PI and addressed areas such as place
of APRN employment, prior use of SCORE tool, description of practice setting, years of APRN
experience, and number of providers in the practice. The second tool was the EBPQ
questionnaire (Appendix D). It was developed by Upton and Dominick in 2006 (Upton & Upton,
2006) to collect data and opinions from healthcare professionals on their use of evidence-based
practice. Answers to the questionnaire are in scale format with 1 = never, 2 = occasionally, 3 =
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usually, and 4 = always. An explanation was given to the participants of no right or wrong
answers and they were to answer with honest recollection as to how they currently practice. The
first section addressed their practice in relation to individual care-how often had they done the
following in a response to a gap in their knowledge. The second section of the EBPQ asked
attendees to self-reflect and rate themselves concerning evidence-based practice, time
constraints, and practice changes (Table 3). The final section addresses self-reporting of research
and informational technology skills. The third tool was the Post Project Implementation Survey
which addressed if the participants were able to implement the evidenced-based SCORE tool
into their practice setting. The fourth tool was the workshop evaluation form created by the PI
and completed by all participants upon conclusion of the presentation (Appendix E).
The attendees were asked to complete both the demographics survey and the EBPQ prior
to the presentation of the workshop. The PI answered any questions if they arose. The PI
collected the completed surveys and placed them in a sealed envelope. After the four-week
project timeframe, the participants were emailed the Post Project Implementation Survey
(Appendix F) to complete. The PPIS was emailed to their home email as stated in the consent.
There were 11 participants who completed the PPIS.
Data Analysis
Demographic Description
There were 24 attendees at the workshop, and 45.8% (n = 11) agreed to continue as
participants in the project (Table 1.). After the one-hour presentation, the attendees were asked to
complete a written workshop evaluation (Appendix E). The workshop evaluation numbers
ranged from 1 = strongly disagree, 2 = somewhat disagree, 3 = agree, and 4 = strongly agree to
be answered honestly after the presentation. The attendees felt the workshop was a valuable
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experience and gained insight and knowledge on the impact of osteoporosis. The evaluations
disclosed that 100% (n = 24) of the attendees were now better able to: (1) learn the devastating
impact of osteoporosis on females (2) identify younger females at risk for low bone mass and (3)
over 83% could utilize the SCORE tool to help screen younger female patients.
Demographic data analysis was completed using SPSS IBM 25 software. The missing
data from the EBPQ was assigned the number 99 and entered into SPSS. The majority of the
participants (54.5%) worked in settings other than Primary Care or Internal Medicine, and most
(90.9%) classified their place of employment as urban. The average number of years of advanced
practice nursing was 11.6 years and ranged from 1.5 years to 43 years. Most participants worked
with other MD’s at their place of employment (75%) with a total of 1-5 APRN’s (75%).

Table 1. Demographics of APRNS’s_________________________________________________
Variables

N

Percentage________

Place of employment
Primary Care/Internal Medicine
4
36.4%
Women’s Health
1
9.1%
Health Dept.
0
0.0 %
Other
6
54.5%
______________________________________________________________________________
Employment setting
Rural
10
90.9%
Urban
1
9.1%
______________________________________________________________________________
Years of Advanced Nursing practice
0-5
4
36.4%
6-10
1
9.1%
11-20
4
36.4%
20+
2
18.2%
______________________________________________________________________________
Providers in the practice setting
MD
0

2

18.2%
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1-5
6-10
10+
(missing entry)

3
2
1
3

27.3%
18.2%
9.1%
27.3%

1-5
6-10
10+
(missing entry)

6
1
1
3

54.5%
9.1%
9.1%
27.3%

APRN

Other Provider
0
4
36.4%
1-5
3
27.3%
6-10
1
9.1%
10+
0
0.0%
(missing entry)
3
27.3%
______________________________________________________________________________
Practice setting
Hospital
Private practice
Health dept
Other

6
4
0
1

54.5%
36.4%
0.0%
9.1%

______________________________________________________________________________

Findings of Research Questions
Research Question 1: Will APRN’s who attend an osteoporosis risk assessment program
implement the SCORE tool into practice?
Findings revealed that 90.9% of the participants (n = 10) planned to continue
incorporating the SCORE tool into practice with the intention of using it as a pre-screening
instrument. One participant indicated that the SCORE tool would not be continued to be used,
which was identified on the PPIS. Prior to the osteoporosis workshop, 63.6% of the participants
reported they had no prior use of the SCORE tool. After the projects’ completion, 91% of the
participants planned to continue using the SCORE instrument as a means to capture those
women (ages 45-64) who might be at risk for low bone mass (Table 4). The participants who
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attended the workshop stated they gained valuable evidence-based information and saw a
definite need to prescreen younger female patients. The increase in pre-screening females will
enable providers to initiate low bone mass education and/or medication regimens sooner.
Patients will gain valuable instruction by the APRN on ways to increase protection of bone mass
if screened earlier.
Research Question #2: Will the EBPQ tool identify APRN’s who will implement change into
practice?
Eighty-three percent of the participants rated themselves as either “always seeing
evidence-based research as fundamental to their practice” (n = 7) or “usually seeing evidencebased research as fundamental to their practice” (n = 2) out of the total 11 APRN project
participants (Table 3). The remaining two participants rated themselves as “never seeing
evidence-based research as fundamental to their practice” (18%). Results concluded that the
APRNs (n = 7) who rated themselves as “always seeing new evidence as fundamental to
professional practice” were more likely to implement change (planned to continue to use the
SCORE tool) than those who rated themselves as “usually seeing new evidence as fundamental
to professional practice” (n = 2). Of the two participants who “usually” saw new evidence as
fundamental to practice, one did not plan to implement change into practice and did not state a
specific reason.
The results reveal that APRNs embrace evidence-based knowledge and research when
incorporating it into their practice settings. APRNs are educated while held to the highest
standards and expected to implement new data and information in keeping with the best interest
of the patient. The APRNs who see new evidence as fundamental to practice will promote health
and awareness to their patients as new data and research becomes available. APRNs are required
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to continue to learn and keep abreast of new healthcare guidelines as they become available.
Many patients prefer to have an APRN as their sole healthcare provider due to the diligent effort
APRNs pour into their patients’ health promotion.
Research Question #3: What work/environmental factors are associated with the
implementation of the SCORE tool into practice?
Over 91% of the participants that planned to continue to implement the SCORE tool into
practice were classified as working in either a hospital or private practice setting (n = 10). The
work and environmental factors associated with implementation of the SCORE tool into practice
disclosed both rural and urban APRNs planned to continue use of the SCORE tool (Table 4).
One participant classified her employment setting as urban and was unable to continue its use for
other reasons, as indicated on the PPIS. APRNs are a valuable key stakeholder when educating
their patients.
The results indicate that rural patients who have little or no access to radiologic DXA
imaging can be pre-screened with a valid evidence-base tool to identify their risk for low bone
mass. Both rural and urban APRNs can educate their female patients on ways to promote optimal
bone mass and prevent further breakdown of skeletal mass. Baseline SCORE results can be
tabulated and entered into the EMR and repeated as needed. The APRN can tract any changes
over the years and proceed to order radiologic imaging if needed while protecting the patient
from unnecessary radiation exposure.
Research Question #4: What are the perceived barriers that prevent implementation of the
SCORE tool into practice?
Over 90% of the APRNs employed in Primary Care, Internal Medicine, Women’s
Health, Health Department, or Other were able to use the SCORE tool and planned to
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incorporate it into their practice (n = 10). There was one participant who did have a barrier that
prevented the use of the SCORE tool after completion of the project. The participant listed the
barrier as “other reason” on the PPIS for explanation as to the barrier. No further information
was given on the barrier by the participant. This participant did rate as “usually seeing new
evidence as fundamental to professional practice.” The participant did not state if they were able
to fully use the SCORE tool for the entire four weeks but did answer the PPIS that was emailed
upon conclusion of the project.
The results indicate there are minimal barriers for APRNs to implement the SCORE tool
into practice. This will assist many healthcare providers in their decision making with regards to
earlier screenings.
Further Findings
The attendees evaluated the workshop as proven to be successful in identifying women
whom they should screen and gained valuable education on use of the SCORE tool. Regarding
the EBPQ, there were six questions in the first section that the participants were asked to
complete (Table 2). Six participants (54.5%) articulated they framed an answerable question at
the beginning of patient care to fill in knowledge gaps regarding their practice. After known gaps
were identified, over 90% of the attendees stated they tracked down pertinent evidence once the
question was identified and critically reviewed the literature for set criteria. Over 90% stated
they integrated newly found evidence into their practice once identified, and 72.% shared this
information with peers/colleagues. After researching and filling knowledge gaps, 72.8% (n = 8)
stated they evaluated the outcomes of their practice changes.
In the second set of questions of the EBPQ (Table 2), the first question addressed
allotting time to incorporate new evidence into practice. Findings indicated 72.7% (n = 8) did
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make time in their schedules. Only 9% (n = 1) stated they never made time for new evidence
regarding their work schedules. Over 90% (n = 9) welcomed questions about their clinical
practice patterns. Results showed that 81.5% usually or always deemed evidence-based practice
as fundamental to their practice, with 54.5% (n = 6) claiming that their practice has changed
because of new evidence they have found and incorporated. Only one participant stated their
practice had not changed because of new evidence being found. There was no further
information given to the PI regarding why they chose or were unable to continue to use the
SCORE tool.
_____________________________________________________________________________________________

Table 2. Evidence-Based Practice Questionnaire (EBPQ)
Questions

Never
n (%)

Occasionally
n (%)

Usually
n (%)

Always
n (%)_____________

Considering your practice in relation to an individual patient’s care over the past year how often
have you done the following in response to a gap in your knowledge
Formulated a clearly
answerable question as
the beginning of the
process towards filling
this gap:

1 (9.1%)

2 (18.2%)

6 (54.5%)

2 (18.2%)

Tracked down the relevant
evidence once you have
formulated the question:

0 (0%)

1 (9.1)

8 (72.7%)

2 (18.2%)

Critically appraised, against
set criteria, any literature
you have discovered:

0 (0%)

1 (9.1%)

8 (72.7)

2 (18.2)

Integrated the evidence you
have found with your
expertise:

0 (0%)

1 (9.1%)

7 (63.6%)

3 (27.35)

Evaluated the outcomes of
your practice:

0 (0%)

3 (27.3%)

5 (45.5%)

3 (27.3%)
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Shared the information with
0 (0)%)
3 (27.2%)
5 (45.5%)
3 (27.3%)
colleagues:
_____________________________________________________________________________________________

_____________________________________________________________________________
Table 3. Evidence-Based Practice Questionnaire (EBPQ)
Questions

Never
Occasionally
Usually
Always
n (%)
n (%)
n (%)
n (%)
______________________________________________________________________________
Please indicate how you would place yourself for each of the following questions.
I make time for new
evidence in my work
schedule:

1 (9.1%)

2 (18.2%)

6 (54.5%)

2 (18.2%)

I welcome questions
regarding my clinical
practice:

1 (9.1%)

1 (9.1%)

4 (36.4%)

5 (54.5%)

0 (0%)

2 (18.2%)

7 (63.3%)

Evidence-based medicine 2 (18.2%)
is fundamental to
professional practice:

My practice has
1 (9.1%)
1 (9.1%)
3 ( 27.3%)
6 (54.5%)
changed because of
evidence I have found:
_____________________________________________________________________________________________

The project participants scored themselves on their prior use of the SCORE tool before
the project and after project implementation (Table 4.). Prior to the workshop, 63.6% (n = 7) of
the participants indicated they had not previously used the SCORE tool. Only 36.4% (n = 4) had
previously used it within the last month on their female patients.
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_____________________________________________________________________________________________

Table 4. (n = 11)
SCORE tool use prior to workshop_________________________________________________
Frequency (n)
Percent (%)
0 times
7
63.6%
1-5 times
4
36.4%
Total
11
100%

SCORE tool use after project______________________________________________________
Frequency (n)
Percent (%)
No-will not use
1
9.1%
Yes-will use
10
91.9%
Total
11
100%

Recommendation and Discussion
The USPSTF guidelines and recommendations regarding screenings for osteoporosis
prove valid and necessary. However, literature is consistent that many younger females are at
risk for low bone density, and healthcare providers are missing opportunities to screen before age
65. The potential to decrease future fragility fractures is overwhelmingly necessary and
imminent (Golob & Laya, 2015). The PI recommends that APRNs continue to use the SCORE
tool for screening younger female patients. The project highlighted the inconsistencies of
screenings and the need for more global awareness of this overwhelming problem. Education for
healthcare providers is imperative to incorporate evidence-based research into practice. The PI
found valuable awareness and current preventative screening information from the USPSTF
website.
Economic/Cost Benefit
The goal of osteoporosis screening is to identify women with lower T-scores (<2.5) so
that appropriate therapy can be initiated and the prevention and/or reduction of potential
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fractures. Data shows that 50% of postmenopausal females will experience an osteoporotic
fracture in her lifetime, and over 200 million women worldwide will be affected by osteoporosis
(Daroszewska, 2015). Although to date there are valid risk assessment tools and radiologic
imaging tests available to identify risk for osteoporosis or confirm diagnosis thereof, Gillespie
and Morin (2017) state screening among women ages 50-64 has declined steadily from 20082014. Osteoporotic related fractures in the U.S. cost approximately $17 billion annually and are
expected to continue to rise as our population ages (Gold et al., 2019). It is estimated that
osteoporotic fractures lead to more than 500,00 hospital admissions annually and account for
greater than 800,000 hospital emergency room visits (Gold et al., 2019). The effect and costs
associated with osteoporosis are also impacted by the burden of non-direct medical costs such as
pain, depression, and poor health. Many women are left to reside in assisted rehabilitation
facilities and suffer from chronic pain and altered function of life. For many patients, the quality
of life is severely impacted, leading to social isolation and mental health challenges. The benefit
of identifying women at risk for low bone mass can prevent future fractures and possibly
mortality. Literature is consistent, stating that morbidity and mortality rates are high postfracture, with 20%-25% of hip fracture patients dying after the first year (Tsai, 2019).
Pharmacological and nonpharmacological interventions are available to increase bone
density to prevent further bone loss. The SCORE risk assessment tool has a high sensitivity in
predicting those females with low bone density and providing healthcare providers an extra tool
to assist with decisions in treatment and further testing. APRNs are in an excellent position to
teach and educate their patients.
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Impact on Healthcare Quality and Safety
The screening and diagnosis of osteoporosis do not lie in the hands of any one particular
healthcare member. The confusion often evolves when patients see varying specialists and
healthcare team members for treatment and observation. Providers might assume a specialist is
providing the screening when, in reality, no screening has been attempted. The SCORE risk
assessment tool is validated as a safe, nonradiologic instrument that helps identify women at risk
for low bone mass. It does not replace the DXA scan-but optimally excludes patients who should
or should not have radiologic imaging. The tool itself takes no longer than one to two minutes to
implement with immediate results viewable. Several websites that provide free online access to
the SCORE tool with results. There is no training necessary for implementing the SCORE tool.
The results of each person’s SCORE outcomes identify them at either low, moderate, or high risk
for low bone mass with 92-95% sensitivity (Pecina, Romanovsky, Merry, Kennel, & Thacher,
2016). Reduction in preventable fragility fractures is a necessary healthcare quality control
outcome.
Policy Implications
Pecina et al. (2016) state that the SCORE tool had a statistically higher sensitivity
threshold in detecting osteoporosis in women ages 50-64 than the current USPSTF guidelines
using FRAX threshold of 9.3%. The SCORE tool, if implemented into a hospital or practicebased setting, could be used as a first-line risk assessment screening instrument for younger
female patients. EMR’s have important screening instruments embedded within the chart.
Educating healthcare personnel to utilize the SCORE tool would help in the decision-making
process of when to start or refer for radiologic DXA screening if low bone mass is suspected.
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The providers would still fully appreciate the USPSTF’s guidelines for initial DXA screening at
age 65 without any disruption in national recommendations or policy.
Translation
The response upon conclusion of the workshop was positive and beneficial. Attendees
asked numerous questions and expressed sincere gratitude for the newly learned content and
value of capturing low bone mass early. There were numerous attendees who expressed interest
in learning more about the SCORE tool and planned to share this information with coworkers
and peers. Numerous attendees who did not meet inclusion criteria for participation also found
value in attending the workshop and use of the SCORE tool.
Pre-screening tools have proven to be a valid and necessary instrument that will help the
APRN in decision-making strategies with regards to DXA imaging. The majority of the
attendees at the workshop planned to make changes within their own practice and lifestyles to
reduce the possibility of low bone mass and fragility fractures. APRNs have a prominent place in
both the healthcare and academic setting. The gainful information learned in this project can be
shared with colleagues and peers.
Limitations
There were several limitations the PI concurred during the implementation of this project.
The primary limitation was the small sample size of participants. The objective was to have at
least thirty participants volunteer for the project. The PI assumes that the small sample size was
due to the workshop held at a location the Cobb/Cherokee chapter typically does not use for
presentation. However, the venue chosen was appreciated by those who attended. Several student
Cobb/Cherokee chapter members who attended the workshop were enthusiastic to start using the
SCORE tool. However, they did not meet the inclusion criteria to be part of the project. A
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limitation was a small amount of missing data information from several participants on the
EBPQ. At the beginning of the workshop, all attendees were asked to complete the EBPQ
completely; however, three attendees missed several areas for completion. Any missing data was
handled by assigning the number 99 and entered into SPSS. The majority of all data was
captured and entered into the specific variable categories.
Discussion
The awareness to implement this project started after the PI witnessed discrepancies in
practice patterns of APRNs in screening for osteoporosis in their places of employment. After
discussion with numerous APRNs regarding their initiation of screening for younger women, the
PI saw the need for this evidence-based project. Many of the APRNs who were questioned about
their screening patterns stated they used the FRAX tool for their older patients but lacked
knowledge on screenings with other evidence-based non-radiologic tools. The PI did not find any
other completed DNP or other research projects addressing the use of non-radiologic screening
tools for younger female patients at risk for low bone mass in numerous repositories.
The PI was able to interview the APRNs who attended the osteoporosis workshop after
its completion. The discussion regarding the workshop was overwhelmingly positive and
appreciated by all who attended. Many of the APRNs voiced sincere appreciation for the new
material learned as they had not recognized the devastating impact of osteoporotic fractures and
their need to address earlier screenings for younger female patients. This evidence-based project
was different from others in the respect that it provided the background of an economic and
burdensome disease (osteoporosis) and followed with a valid screening instrument that can be
used by any healthcare member if applied. The PI was also able to assess the APRNs self-rated
scores on the EBPQ and input that data into the final results of this project.
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The PI carefully examined the literature for project needs and validity. The PI found
sufficient need for the project-based upon literature review and APRN feedback. The consensus
of the literature on when to screen younger female patients coincided with the APRN’s responses
on the pre-project survey in which 33% (n = 8) did not know the current screening guidelines.
The participants voiced appreciation and confidence in understanding their role as providers to
use the SCORE tool as a pre-screening instrument. Those who attended the workshop expressed
gratitude in learning of the impact of osteoporosis and screening patients.
Dissemination
After the four-week use of the SCORE tool, the PPIS form was emailed to all participants
via Qualtrics platform delivery system. The PI then gathered project data results and input those
results into SPSS. The participants were notified of the results of the project in a post-project
email. The email included aggregate data regarding evidence-based changes the participants plan
to make in using the SCORE tool in their practice setting. No personal information was included
in the aggregate data results. Results of the project were shared with the Cobb/Cherokee UAPRN
members.
Professional Reporting
The PI submitted a poster abstract to the 2019 Unity Conference committee poster chair.
The abstract included the required specifications and met all criteria. The PI was notified three
weeks later that the abstract had been accepted by the conference committee. Permission to
display the project poster was granted, and the PI was notified via email that the poster could be
displayed. The PI completed a two-day project poster presentation at the 2019 Unity Conference
held in Atlanta, GA. The PI was available to participants at the Unity Conference for questions
or explanations.
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Evidence-based practice is ever changing and noted to be one of the most influential
factors in the decision-making process. The PI plans to publish the results of the project in one of
several nurse practitioner journals. The goal of this project was to improve screening patterns by
APRNs of their younger female patients. Results from the project indicated the evidence-based
and validated screening tool SCORE could be used as part of the APRNs screening patterns due
to the success of the project.
PI Recommendation
The goal of this project was to bring awareness of a need to screen younger females at
risk for low bone mass. Research supports the literature findings that osteoporosis screenings in
females are inconsistent, and providers lack consistent methodologies in doing them. The
inconsistent screenings were noted nationally as well as globally (Gillespie & Morin, 2016). The
ultimate result is to capture and pre-screen younger females who might be at risk and prevent
future fractures. The evidence is consistent that lifestyle changes, medication, exercise, and
dietary supplements can reverse bone loss and increase bone matrix. The recommendation and
findings of this project by the PI are to incorporate nonradiologic pre-screening tools into the
APRN student curriculum and increase awareness of the devastating impact of osteoporosis. The
project workshop increased significant awareness to each individual who attended. The APRNs
who proceeded to use the SCORE tool will now be able to accurately identify younger females at
risk for low bone mass by using an evidence-based pre-screening tool.
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Appendix A
Simple Calculated Osteoporosis Risk Estimation (SCORE)
Criteria:

A.
B.
C.
D.

Race not black:
Rheumatoid Arthritis:
Fracture after age 45 of wrist, hip or rib:
Age over 65:

E. Weight:
F. Estrogen therapy never used:

5 points
4 points
4 points per fracture
Calculate 3 x 1st digit of age (example age
70 = 21points)
Calculate -1 x weight in pounds/10
(example weight of 200 pounds= -20 points)
1 point______________________________
_______ Total points

SCORE Total:
16-50 Points: High Risk
7-15 Points: Moderate Risk
0-6 Points: Low Risk
Notes:
Interpretation
A.
B.
C.
D.

Score of 6 or above is associated with T-Score below -2 (osteopenia/low bone mass)
Osteoporosis testing with DEXA Scan is recommended if Score of 6 or above
Test Sensitivity: 91%
40%
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Appendix B
INFORMED CONSENT

(Osteoporosis Awareness Screening Program)
I, _________________________________________________, agree to participate in the research {Osteoporosis
Program}, which is being conducted by Linda Gay DNP-S, who can be reached at lindalgay@gmail.com/6780-2315218. I understand that my participation is voluntary; I can withdraw my consent at any time. If I withdraw my
consent, my data will not be used as part of the study and will be destroyed.
The following points have been explained to me:

1.
2.

3.

4.

5.

6.

7.
8.
9.
10.

The purpose of this study is to identify females (45-64 years of age) who may be at hirisk or higher than normal risk in developing osteoporosis.
The procedures are as follows: you will be asked to:
a. Attend the Osteoporosis Program
b. Sign the informed consent
c. Become familiar with the SCORE risk assessment tool
d. Offer the SCORE risk assessment tool to your female patients (ages 45-64)
e. Complete the daily tally forms and place in a locked area
Your name will not be connected to your data. Therefore, the information gathered will
be confidential. Only the Principal Investigator will have access to the master list of ID
numbers and data. Your information will be stored in a locked box and/or a password
protected computer in the Principal Investigators locked office at home.
You will be asked to sign two identical consent forms. You must return one form to the
investigator before the study begins, and you may keep the other consent form for your
records.
This research project is being conducted because of its potential benefits, either to
individuals or to humans in general. The expected benefits of this study include
identifying younger women at risk for osteoporosis.
You are not likely to experience physical, psychological, social, or legal risks beyond
those ordinarily encountered in daily life or during the performance of routine
examinations or tests by participating in this study.
Your individual responses will be confidential and will not be released in any
individually identifiable form without your prior consent unless required by law.
The investigator will answer any further questions about the research should you have
them now or in the future (see above contact information).
In addition to the above, further information, including a full explanation of the purpose
of this research, will be provided at the completion of the research project on request.
By signing and returning this form, you are acknowledging that you are 18 years of age
or older.

Signature of Investigator

Date
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Date

Research at Georgia College involving human participants is carried out under the oversight of the Institutional
Review Board. Address questions or problems regarding these activities to the GC IRB Chair, email: irb@gcsu.edu.
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Appendix C
Practice Demographic Characteristic Survey
Participant ID number:________________
Please answer the following questions (circle your answer).
1-APRN place of employment:
a.
b.
c.
d.

Primary Care/Internal Medicine
Women’s Health
Health dept.
Other (please describe) ________________________

2-In the past month how often have you used a non-radiologic risk assessment tool to screen for
osteoporosis in your pt. population?
a. 0 times
b. 1-5 times
c. 6-10 times
d. >10 times
3-In the past month how often have you used the SCORE osteoporosis risk assessment tool in
your patient population?
a. 0 times
b. 1-5 times
c. 6-10 times
d. > 10 times
4-In the past month how often have you ordered a DEXA scan to screen for osteoporosis in your
patient population?
a. 0 times
b. 1-5 times
c. 6-10 times
d. > 10 times
5-Your practice setting would be considered:
a. Urban - (urbanized areas of 50,000 or more people or urban
clusters of at least 2,500-50,000 people0
b. Rural – (all population, housing, and territory not included
within an urban area)
6-Enter number of years of Advanced Nursing Practice:
a. ______________
7- How many providers are in your practice?
a. __________# of MD’s
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b. __________# of APRNs
c. __________ Other
8. How would you describe your practice setting:
a. Hospital practice
b. Private practice
c. Other
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Appendix D

Evidence Based Practice Questionnaire (EBPQ).
This questionnaire is designed to gather information and opinions on the use of evidence based practice
amongst health professionals. There are no right or wrong answers for we are interested in your opinions
and your own use of evidence in your practice.

1. Considering your practice in relation to an individual patient’s care over the past year,
how often have you done the following in response to a gap in your knowledge (please √
or X):
Formulated a clearly answerable question as the beginning of the process
towards filling this gap:







Never
Frequently
Tracked down the relevant evidence once you have formulated the question:







Never
Frequently
Critically appraised, against set criteria, any literature you have discovered:







Never
Frequently
Integrated the evidence you have found with your expertise:







Never

Frequently

Evaluated the outcomes of your practice:




Never







Frequently

Shared this information with colleagues:




Never







Frequently

2. Please indicate (by √ or X) where on the scale you would place yourself for each of the
following pairs of statements:
My workload is too great for        New evidence is so
me to keep up to date with
important that I make the
all the new evidence
time in my work schedule
       I welcome questions on my
I resent having my clinical
practice questioned
practice







Evidence based practice is
Evidence based practice is
a waste of time
fundamental to professional
practice







I stick to tried and trusted
My practice has changed
methods rather than
because of evidence I have
changing to anything new
found
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3. On a scale of 1 to 7 (with 7 being the best) how would you rate your:
Please circle one number for each statement
Poor
Research skills
1
2
3
4
5
IT skills
1
2
3
4
5
Monitoring and reviewing of practice skills
1
2
3
4
5
Converting your information needs into a research
1
2
3
4
5
question
Awareness of major information types and sources
1
2
3
4
5
Ability to identify gaps in your professional practice
1
2
3
4
5
Knowledge of how to retrieve evidence
1
2
3
4
5
Ability to analyse critically evidence against set
1
2
3
4
5
standards
Ability to determine how valid (close to the truth) the
1
2
3
4
5
material is
Ability to determine how useful (clinically applicable)
1
2
3
4
5
the material is
Ability to apply information to individual cases
1
2
3
4
5
Sharing of ideas and information with colleagues
1
2
3
4
5
Dissemination of new ideas about care to
1
2
3
4
5
colleagues
Ability to review your own practice
1
2
3
4
5
4. Finally, some information about you:
Your profession:

Year qualified:

Your position/grade:

Your speciality:

Please circle the most appropriate answer as it concerns you:
Your sex:

Male

Female

Your age range:

20-29 30-39 40-49 50-59 60-69

60

Best
6
7
6
7
6
7
6
7
6
6
6
6

7
7
7
7

6

7

6

7

6
6
6

7
7
7

6

7
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Appendix E
AANP CE Activity Evaluation
Activity Title: Identifying Females at Risk for Osteoporosis and Low Bone Mass Using a NonRadiologic Screening Tool (SCORE)
Activity ID # 5396033609
Cobb

Date: September 4th, 2019

Location: Sterling Estates of West

Circle the number that best fits your evaluation of this activity:
4=strongly agree
3=agree
2=somewhat disagree
1=strongly disagree

1. As a result of my participation in this activity, I am better able to:
a. Learn the devastating impact of osteoporosis on females

4

3

2

1

b. Identify younger females at risk for low bone mass

4

3

2

1

c. Utilize non-radiologic screening tools to help screen female patients 4

3

2

1

2. The following speaker demonstrated experiential knowledge of the topic.
a. Linda Gay

4

3

2

1

3. The content provided a fair and balanced coverage of the topic.

4

3

2

1

4. The content was free of commercial bias.

4

3

2

1

5. Would like to receive more CE opportunities for NP’s through UAPRN

4

3

2

1
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Appendix F
Post Project Implementation Survey (PPIS)

ID Number________________
Please answer the following questions.

1-Was the SCORE tool implemented into your practice setting after attending the evidenced -based
osteoporosis workshop?
____Yes
____ No (if no please proceed to question #2)

2-If you did not implement the SCORE tool into your practice setting what barriers prevented
you from doing so: (you may select more than one)
____ Time constraints
____ Practice policies
____ Alternative screening tools
____ Lack of evidence
____ Lack of support from MD’s
____ Lack of support from APRN’s
____ Other (Please answer below)

Other:
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Appendix G

Project Timeline

EBP II N3300
Literature review
Project Chair
appointment
Project committee
selection
Approval for project
development
EBP III N9300
Study participant named
Proposal approved
Tools identified and
created
Translational and
Clinical Research N930
Osteoporosis invite
Workshop presentation
Implementation of
SCORE tool
Gather Data
Translational and
Clinical Research II
Evaluate project
effectiveness
Complete written
proposal/.report
Project final defense

May

April

March

February

January

December

November

October

September

2020

August

July

June

May

April

2019

March

Action
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Appendix H

Appendix G
August 14, 2019
Linda Gay
147 Threechop Drive
Marietta, GA. 30064
Dear Linda,
The continuing education activity “Educational workshop: Identifying Females at Risk for Low
Bone Mass Using a Non-Radio-logic Screening Tool (SCORE)”, sponsored by Linda Gay, is
approved for continuing education by the American Association of Nurse Practitioners. Activity
ID number 19073804 has been assigned to this application. All sessions are approved as
submitted. This activity has been approved for 1 year (through August 31, 2020), provided no
changes are made.
This activity may be repeated 1 additional time within the approval year with appropriate
notification per the AANP Accreditation policy.
Use the following statement in your literature to indicate the maximum credit one person can
obtain upon completion of this activity: “This activity is approved for 1.5 contact hour(s) of
continuing education by the American Association of Nurse Practitioners. Activity ID 19073804.
This activity was planned in accordance with AANP Accreditation Standards and Policies.”
This approval is for the continuing education activity listed in the original application. With this
approval, ALL changes to this program must be reported to the AANP for review as soon as they
are identified. This includes, but is not limited to:
•
•
•
•

session drops/additions
speaker changes
objective changes
date and /or venue changes

AN OSTEOPOROSIS RISK ASSESSMENT WORKSHOP

65

Any changes to content or speakers that are not reviewed by the AANP are not approved for
credit.
Refer to this activity’s ID number with all communication pertaining to this application
including the required post-activity reports. Attendance sheets and evaluation summaries are due
to AANP one month after the activity’s initial presentation (no later than October 4, 2019).
Please find important information and instructions attached regarding mandatory post-activity
reporting.

Best Regards,
AANP Accreditation
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Appendix I
IRB Approval
Institutional Review Board
Office of Academic Affairs
irb@gcsu.edu
http://www.gcsu.edu/irb
DATE: 2019-07-11
TO: Linda L. Gay
FROM: Sallie Coke, Ph.D., APRN, BC Chair of Georgia College Institutional Review Board
PROJECT TITLE: #11983 Implementation of an osteoporosis workshop for APRN’s to identify
female patients at risk for low bone mass
ACTION: DETERMINATION OF EXEMPT STATUS
DECISION DATE: 2019-07-11
REVIEW CATEGORY: Exempt
Thank you for submitting an application to the Georgia College IRB for the above-referenced
project. Based on the information you provided in your submission, IRB has determined that
your project involving human subjects qualifies for EXEMPT status under 45CFR part 46
commonly known as the Revised Common Rule 2018.
Assignment of exempt status to this project means that this project is exempt from further IRB
review. This exempt status is valid unless substantive revisions to the study design occur which
would alter the risk to participants. If a substantive change is anticipated, you may submit an
extension/modification form detailing these changes. Please consult the GC IRB if you have a
question about a potential change to your exempt study.
Please note that all responsibilities required of conducting human subject research still apply to
this project. Specifically, the Belmont Report principles of respect for persons, beneficence, and
justice apply, and all investigators involved in this project must have and maintain current/valid
certification of training with conducting research with human subjects
We will retain a copy of this correspondence within our records.
If you have any questions, please contact irb@gcsu.edu. Please include your project title and
reference number in all correspondence with this committee.
This letter has been electronically signed in accordance with all applicable regulations, and a
copy is retained within Georgia College IRB's records.
Sincerely,
Sallie Coke, Ph.D., APRN, BC

